Rheumatoid Arthritis Clinical Trials in New York

Showing 1061-1080 of 4,168 trials

OCS DCD Heart + CAP Continued Follow-Up

NCT05741723

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Heart Transplant

TransMedics276 participantsStarted Nov 2019

La Jolla, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +17 more locations

Active Not RecruitingPhase 3< 1 mile

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

NCT00978458

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether radiation therapy is more effective when given together with or without temozolomide in treating patients with low-grade glioma. PURPOSE: This randomized phase III trial is studying radiation therapy so see how well it works when given together with or without temozolomide in treating patients with low-grade glioma.

Brain and Central Nervous System TumorsNeurotoxicity

Eastern Cooperative Oncology Group540 participantsStarted Nov 2009

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +165 more locations

OCS DCD Heart + CAP Continued Follow-Up

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Rheumatoid Arthritis Trials in Other Cities

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

The EBC Recovery Study

Effect of Treatment Modality on Psychosocial Functioning of Survivors of Unilateral Retinoblastoma

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Expanded Access Program for Revumenib

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

Combinatory Rehabilitation Used for Substantially Helping Individuals With Traumatic Brain Injury

Mitral Valve Screening Survey

GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

MR Image Synthesis With Low Gadobutrol Dose and AI

Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

Other Conditions in New York